Evidence map›Paper›PMID 31887604›Full record

ArticleDrug and alcohol dependence2020

Greater delay discounting and cannabis coping motives are associated with more frequent cannabis use in a large sample of adult cannabis users.

Michael J Sofis, Alan J Budney, Catherine Stanger, Ashley A Knapp, Jacob T Borodovsky

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Which came first: Cannabis use or deficits in impulse control?Progress in neuro-psychopharmacology & biological psychiatry · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Michael J SofisGeisel School of Medicine, Dartmouth College, Center for Technology and Behavioral Health, 46 Centerra Parkway, Suite 315, Lebanon, NH, USA. Electronic address: michael.j.sofis@dartmouth.edu.
Alan J BudneyGeisel School of Medicine, Dartmouth College, Center for Technology and Behavioral Health, 46 Centerra Parkway, Suite 315, Lebanon, NH, USA.
Catherine StangerGeisel School of Medicine, Dartmouth College, Center for Technology and Behavioral Health, 46 Centerra Parkway, Suite 315, Lebanon, NH, USA.
Ashley A KnappDepartment of Preventive Medicine, Northwestern University Center for Behavioral Intervention Technologies (CBITs), 750 N. Lake Shore Drive Chicago, IL, 60611, USA.
Jacob T BorodovskyDepartment of Psychiatry, Washington University School of Medicine in St. Louis, 660 South Euclid Avenue, Box 8134, St. Louis, MO, 63110, USA. Electronic address: jborodovsky@wustl.edu.
Dartmouth College · USNorthwestern University · USWashington University in St. Louis · US

Funding

Treatment Development & Evaluation CoreP30DA029926 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2011 to 2026
$21.5M
Training in the Science of Co-Occurring DisordersT32DA037202 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2014 to 2026
$4.7M
Multidisciplinary Training Program in Digital Mental HealthT32MH115882 · NIMH · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Darren Gergle, DAVID CURTIS MOHR · 2018 to 2026
$2.4M
Assessing the Contribution of Alcohol and Psychotropic Medication Use to Upward US Injury and Poisoning TrendsF32AA027941 · NIAAA · WASHINGTON UNIVERSITY · PI BORODOVSKY, JACOB T · 2019 to 2020
$94k
NIAAA NIH HHS F32 AA027941NIDA NIH HHS P30 DA029926NIDA NIH HHS T32 DA037202NIMH NIH HHS T32 MH115882
6 · The paper itself

Abstract

backgroundSelf-regulation deficits expressed through a decreased ability to value future rewards (delay discounting (DD)) and impaired emotion regulation (negative urgency (NU), cannabis coping motives (CCM), and anxiety sensitivity (AS)) relate to more frequent or problematic cannabis use. However, there is a need to better understand how self-regulation and emotion regulation constructs reflect competition between deliberative and reactive systems that drive individual differences in cannabis use patterns. Further, few studies assess frequency of cannabis use within and across days of use, which may obscure differentiation of individual differences.

methodsIn a large national sample of 2545 cannabis users, Latent Class Analysis was used to derive participant sub-classes based on two frequency indices, self-reported cannabis use days and times cannabis was used per day. Three classes emerged: Low (1-9 days/month, 1 time/day; 23 %), moderate (10-29 days/month, 2-3 times/day; 41 %), and high (30 days/month, ≥4 times/day; 36 %). Relationships among frequency classes and emotional regulation and impulsivity were assessed with a multinomial logistic regression.

resultsHigher frequency use was associated with greater DD (χ

conclusionsIdentifying meaningful patterns of cannabis use may improve our understanding of individual differences that increase risk of frequent or problematic cannabis use. Excessive delay discounting and using cannabis to cope with negative affect may be relevant targets for treatments designed to reduce cannabis use.

Indexed as

Delay DiscountingAdaptation, PsychologicalAdultAnxietyEmotional RegulationFemaleHumansImpulsive BehaviorLatent Class AnalysisMaleMarijuana AbuseMotivationRewardSelf ReportAnxiety sensitivityCannabisCannabis coping motivesDelay discountingLatent class analysisMarijuana

Identifiers

PMID31887604
PMCPMC7147078
OpenAlexW2997593926

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.